福元医药：关于地屈孕酮片获得药品注册证书的公告

Group 1 - The core point of the article is that Fuyuan Pharmaceutical announced the approval of its subsidiary Zhejiang Aisheng Pharmaceutical's drug, Dydrogesterone Tablets (10mg), by the National Medical Products Administration [2][3] Group 2 - The drug has received a production license, indicating a significant milestone for the company [2] - This approval may enhance the company's product portfolio and market presence in the pharmaceutical industry [2]